世界のmiRNAのシーケンスおよびアッセイの市場規模は、2028年までに5億9,780万USドルに達する見込みです。同市場は、2021年から2028年にかけて13.0%のCAGRで拡大すると予測されています。Illumina社、PerkinElmer社、Qiagen社などの著名な企業は、複数の臨床アプリケーション向けの高度なmiRNAシーケンス製品を提供しています。 さらに、これらの企業は研究機関と協力して、研究におけるmiRNAシーケンシングとアッセイのアプリケーションを拡大しています。
医療部門における用途の拡大が大きな成長の可能性を示しています。例えば、いくつかの研究では、癌（乳癌、卵巣癌、子宮頸癌など）、心血管疾患、敗血症、神経系疾患などの診断と予後において、miRNAが効率的なバイオマーカーとして使用できることが示されています。そのため、臨床疾患における遺伝子制御を解析するために、miRNAの配列解析を行うことが多くなっています。
COVID-19で回復した患者の血漿は、抗ウイルス性のmiRNAと抗体が豊富であるため、SARS-CoV-2に感染した患者の治療に使用されています。これにより、ウイルスだけでなく患者からのmiRNA（マイクロRNA）の配列分析に焦点を当てた研究が増加しています。
目次
Table of Content
Chapter 1 Methodology and Scope
1.1 Research Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR's Internal Database
1.3.3 Secondary Sources
1.3.3.1 List of secondary data sources
1.3.4 Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.5.1 Region-wise market: Base estimates
1.6 Objectives
1.6.1 Objective 1:
1.6.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Industry Pyramid Analysis
3.1.1 Parent & ANCILLARY Market Analysis
3.2 Market Segmentation & Scope
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Advantages of miRNA Sequencing
3.3.1.2 MiRNAs as critical regulators of health and disease
3.3.1.3 Rise in prevalence of cancer and autoimmune disorders
3.3.1.4 Rise in adoption of RNA sequencing protocols in biotechnology research
3.3.2 Market restraint analysis
3.3.2.1 Limitations associated with Bioinformatic Analysis of MicroRNA Sequencing Data
3.3.3 Market opportunity analysis
3.3.3.1 Efforts taken to optimize miRNA-seq data processing
3.3.4 Market challenge analysis
3.3.4.1 Challenges associated with the validation and prediction of miRNA targetome
3.4 Penetration & Growth Prospect Mapping for Technology, 2020
3.5 COVID-19 Impact Analysis on Market
3.6 BUSINESS ENVIRONMENT ANALYSIS
3.6.1 MiRNA sequencing and assay Market - SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.6.2 Porter's Five Forces Analysis
3.7 Major Deals & Strategic Alliances Analysis
3.7.1 Product developments
3.7.2 Merger & acquisition
3.7.3 Agreement
3.7.4 Collaboration & partnership
Chapter 4 Product & Service Business Analysis
4.1 miRNA sequencing and assay market: Product & Services Movement Analysis, 2020 & 2028
4.2 Products
4.2.1 MiRNA Sequencing and Assay Products Market, 2017 - 2028 (USD Million)
4.2.2 Library Preparation Kits
4.2.2.1 Library Preparation Kits market, 2017 - 2028 (USD Million)
4.2.3 Sequencing Consumables
4.2.3.1 Sequencing Consumables market, 2017 - 2028 (USD Million)
4.2.4 Instruments
4.2.4.1 Instruments market, 2017 - 2028 (USD Million)
4.3 Services
4.3.1 MiRNA Sequencing and Assay Services Market, 2017 - 2028 (USD Million)
Chapter 5 Technology Business Analysis
5.1 miRNA sequencing and assay market: Technology Movement Analysis, 2020 & 2028
5.2 Sequencing by Synthesis
5.2.1 Sequencing By Synthesis Market, 2017 - 2028 (USD Million)
5.3 Sequencing by Oligonucleotide Ligation and Detection (SOLiD)
5.3.1 Sequencing By Oligonucleotide Ligation and Detection (SOLiD) Market, 2017 - 2028 (USD Million)
5.4 Nanopore Sequencing
5.4.1 Nanopore Sequencing Market, 2017 - 2028 (USD Million)
5.5 Sanger Sequencing
5.5.1 Sanger Sequencing Market, 2017 - 2028 (USD Million)
5.6 Single Molecule Real-time (SMRT) Sequencing
5.6.1 Single Molecule Real-time (SMRT) Sequencing Market, 2017 - 2028 (USD Million)
Chapter 6 Workflow Business Analysis
6.1 miRNA Sequencing and Assay Market: Workflow Movement Analysis, 2020 & 2028
6.2 Library Preparation
6.2.1 Library Preparation Workflow Market, 2017 - 2028 (USD Million)
6.3 Sequencing
6.3.1 Sequencing Workflow Market, 2017 - 2028 (USD Million)
6.4 Data Analysis & Storage
6.4.1 Data Analysis & Storage Workflow Market, 2017 - 2028 (USD Million)
Chapter 7 Application Business Analysis
7.1 miRNA Sequencing And Assay Market: Applications Movement Analysis, 2020 & 2028
7.2 Cancer
7.2.1 Cancer Market, 2017 - 2028 (USD Million)
7.3 Polyglutamine Diseases
7.3.1 Polyglutamine Diseases Market, 2017 - 2028 (USD Million)
7.4 Autoimmune Disease
7.4.1 Autoimmune Disease Market, 2017 - 2028 (USD Million)
7.5 Schizophrenia
7.5.1 Schizophrenia Market, 2017 - 2028 (USD Million)
7.6 Others
7.6.1 Others Market, 2017 - 2028 (USD Million)
Chapter 8 End-use Business Analysis
8.1 miRNA Sequencing And Assay Market: End-use Movement Analysis, 2020 & 2028
8.2 Pharmaceutical & Biotechnology Industry
8.2.1 Pharmaceutical & Biotechnology Industry Market, 2017 - 2028 (USD Million)
8.3 Research and Academic Institutes
8.3.1 Research and Academic Institutes Market, 2017 - 2028 (USD Million)
8.4 Contract Research Organizations
8.4.1 Contract Research Organizations Market, 2017 - 2028 (USD Million)
Chapter 9 Regional Business Analysis
9.1 MiRNA Sequencing & Assay Market Share By Region, 2020 & 2028
9.2 North America
9.2.1 North America MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
9.2.2 U.S.
9.2.2.1 U.S. miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
9.2.2.2 U.S. miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
9.2.2.3 U.S. miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
9.2.2.4 U.S. miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
9.2.2.5 U.S. miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
9.2.3 Canada
9.2.3.1 Canada miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
9.2.3.2 Canada miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
9.2.3.3 Canada miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
9.2.3.4 Canada miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
9.2.3.5 Canada miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
9.3 Europe
9.3.1 Europe MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
9.3.2 U.K.
9.3.2.1 U.K. miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
9.3.2.2 U.K. miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
9.3.2.3 U.K. miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
9.3.2.4 U.K. miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
9.3.2.5 U.K. miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
9.3.3 Germany
9.3.3.1 Germany miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
9.3.3.2 Germany miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
9.3.3.3 Germany miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
9.3.3.4 Germany miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
9.3.3.5 Germany miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
9.3.4 France
9.3.4.1 France miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
9.3.4.2 France miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
9.3.4.3 France miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
9.3.4.4 France miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
9.3.4.5 France miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
9.3.5 Italy
9.3.5.1 Italy miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
9.3.5.2 Italy miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
9.3.5.3 Italy miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
9.3.5.4 Italy miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
9.3.5.5 Italy miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
9.3.6 Spain
9.3.6.1 Spain miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
9.3.6.2 Spain miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
9.3.6.3 Spain miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
9.3.6.4 Spain miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
9.3.6.5 Spain miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
9.4.2 China
9.4.2.1 China miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
9.4.2.2 China miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
9.4.2.3 China miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
9.4.2.4 China miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
9.4.2.5 China miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
9.4.3 Japan
9.4.3.1 Japan miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
9.4.3.2 Japan miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
9.4.3.3 Japan miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
9.4.3.4 Japan miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
9.4.3.5 Japan miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
9.4.4 India
9.4.4.1 India miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
9.4.4.2 India miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
9.4.4.3 India miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
9.4.4.4 India miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
9.4.4.5 India miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
9.4.5 Australia
9.4.5.1 Australia miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
9.4.5.2 Australia miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
9.4.5.3 Australia miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
9.4.5.4 Australia miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
9.4.5.5 Australia miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
9.4.6 South Korea
9.4.6.1 South Korea miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
9.4.6.2 South Korea miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
9.4.6.3 South Korea miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
9.4.6.4 South Korea miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
9.4.6.5 South Korea miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
9.5 Latin America
9.5.1 Latin America MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
9.5.2 Brazil
9.5.2.1 Brazil miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
9.5.2.2 Brazil miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
9.5.2.3 Brazil miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
9.5.2.4 Brazil miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
9.5.2.5 Brazil miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
9.5.3 Mexico
9.5.3.1 Mexico miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
9.5.3.2 Mexico miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
9.5.3.3 Mexico miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
9.5.3.4 Mexico miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
9.5.3.5 Mexico miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
9.6 MEA
9.6.1 MEA MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
9.6.2 South Africa
9.6.2.1 South Africa miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
9.6.2.2 South Africa miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
9.6.2.3 South Africa miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
9.6.2.4 South Africa miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
9.6.2.5 South Africa miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
9.6.3 Saudi Arabia
9.6.3.1 Saudi Arabia miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
9.6.3.2 Saudi Arabia miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
9.6.3.3 Saudi Arabia miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
9.6.3.4 Saudi Arabia miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
9.6.3.5 Saudi Arabia miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Chapter 10 COMPETITIVE LANDSCAPE
10.1 Company categorization
10.2 Strategy framework
10.2.1 Thermo Fisher Scientific, Inc.
10.2.1.1 Company overview
10.2.1.2 Financial performance
10.2.1.3 Product benchmarking
10.2.1.4 Strategic initiatives
10.2.2 Illumina, Inc.
10.2.2.1 Company overview
10.2.2.2 Financial Performance
10.2.2.3 Product benchmarking
10.2.3 QIAGEN
10.2.3.1 Company overview
10.2.3.2 Financial Performance
10.2.3.3 Product benchmarking
10.2.4 PerkinElmer, Inc.
10.2.4.1 Company overview
10.2.4.2 Financial Performance
10.2.4.3 Product benchmarking
10.2.5 Abcam plc
10.2.5.1 Company overview
10.2.5.2 Financial Performance
10.2.5.3 Product benchmarking
10.2.6 New England Biolabs
10.2.6.1 Company overview
10.2.6.2 Financial Performance
10.2.6.3 Product benchmarking
10.2.7 Takara Bio Inc.
10.2.7.1 Company overview
10.2.7.2 Financial Performance
10.2.7.3 Product benchmarking
10.2.7.4 Strategic initiatives
10.2.8 Lexogen GmbH
10.2.8.1 Company overview
10.2.8.2 Financial Performance
10.2.8.3 Product benchmarking
10.2.8.4 Strategic initiatives
10.2.9 Norgen Biotek Corp.
10.2.9.1 Company overview
10.2.9.2 Financial Performance
10.2.9.3 Product benchmarking
10.2.9.4 Strategic initiatives
10.2.10 Maravai LifeSciences
10.2.10.1 Company overview
10.2.10.1.1 TriLink BioTechnologies
10.2.10.2 Financial Performance
10.2.10.3 Product benchmarking
10.2.10.4 Strategic initiatives
10.2.11 HTG Molecular Diagnostics, Inc.
10.2.11.1 Company overview
10.2.11.2 Financial performance
10.2.11.3 Product benchmarking
10.2.11.4 Strategic initiatives
10.2.12 Meridian Bioscience, Inc.
10.2.12.1 Company overview
10.2.12.2 Financial performance
10.2.12.3 Product benchmarking
10.2.12.4 Strategic initiatives
10.2.13 System Biosciences, LLC.
10.2.13.1 Company overview
10.2.13.2 Financial Performance
10.2.13.3 Product benchmarking
